Adding chemotherapy to hormonal therapy prolongs survival in metastatic prostate cancer, study finds

BMJ. 2015 Aug 5:351:h4253. doi: 10.1136/bmj.h4253.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Taxoids / therapeutic use*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents
  • Taxoids